Shanghai Medicilon (688202) Stock Overview
A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
688202 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Shanghai Medicilon Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥66.51 |
| 52 Week High | CN¥84.70 |
| 52 Week Low | CN¥25.10 |
| Beta | 1.06 |
| 1 Month Change | 17.16% |
| 3 Month Change | 4.58% |
| 1 Year Change | 132.88% |
| 3 Year Change | -59.89% |
| 5 Year Change | -50.24% |
| Change since IPO | 83.61% |
Recent News & Updates
Recent updates
Shanghai Medicilon Inc.'s (SHSE:688202) 30% Share Price Surge Not Quite Adding Up
Feb 20
Slammed 26% Shanghai Medicilon Inc. (SHSE:688202) Screens Well Here But There Might Be A Catch
Jan 06Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks
Sep 27Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?
Jun 07Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower
Apr 25Shareholder Returns
| 688202 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -7.0% | 2.3% | 0.4% |
| 1Y | 132.9% | 74.8% | 34.6% |
Return vs Industry: 688202 exceeded the CN Life Sciences industry which returned 74.8% over the past year.
Return vs Market: 688202 exceeded the CN Market which returned 34.6% over the past year.
Price Volatility
| 688202 volatility | |
|---|---|
| 688202 Average Weekly Movement | 7.0% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 2.9% |
Stable Share Price: 688202 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688202's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,717 | Chun-Lin Chen | www.medicilon.com.cn |
Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers medicinal and analytical chemistry; process development; custom and zoom in synthesis; structural, in vitro, and computational biology; protein expression and purification; protein crystallization; and recombinant kinase preparation services, as well as protein target validation, compound activity screening and optimization, raw material and preparation process research, and quality standards and stability research services.
Shanghai Medicilon Inc. Fundamentals Summary
| 688202 fundamental statistics | |
|---|---|
| Market cap | CN¥8.75b |
| Earnings (TTM) | -CN¥231.86m |
| Revenue (TTM) | CN¥1.08b |
Is 688202 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688202 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.08b |
| Cost of Revenue | CN¥935.72m |
| Gross Profit | CN¥143.26m |
| Other Expenses | CN¥375.12m |
| Earnings | -CN¥231.86m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Apr 23, 2026
| Earnings per share (EPS) | -1.76 |
| Gross Margin | 13.28% |
| Net Profit Margin | -21.49% |
| Debt/Equity Ratio | 17.1% |
How did 688202 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/19 00:29 |
| End of Day Share Price | 2026/01/19 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shanghai Medicilon Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |